Cipher Pharmaceuticals Incis A Canadian Specialty Pharmaceutical Company Based In Mississaugaontariofounded In 2000The Company Focuses On Acquiringdevelopingand Commercializing Pharmaceutical Products That Address Unmet Medical Needscipher Has A Diverse Portfolio That Includes Both Marketed And Pipeline Productswith A Strong Emphasis On Maintaining A Robust Pipeline And Positive Operating Cash Flow The Company S Commercial Products Include Treatments For Severe Acnehead Licechronic Painand Cardiovascular Conditionsamong Otherscipher Markets Its Products Directly In Canada And Collaborates With Partners For Distribution In The U Sand South Americathe Company Actively Seeks Opportunities For Mergersacquisitionsand Licensing To Enhance Its Portfolioparticularly In Commercial Stage Productsunder The Leadership Of Ceo Craig Mullcipher Emphasizes Strategic Growth And Efficient Management
